“OUTCOMES OF SUBSEQUENT TREATMENT AFTER ATEZOLIZUMAB–BEVACIZUMAB FOR HEPATOCELLULAR CARCINOMA”. 2026. Vietnam Journal of Community Medicine 67 (10). https://doi.org/10.52163/yhc.v67i10.6872.